RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/21380526http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21380526http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21380526http://www.w3.org/2000/01/rdf-schema#comment"To optimize Chinese hamster ovary (CHO) cell culture to recombinant protein therapeutic production, we stably overexpressed survivin and cyclin D1 in three CHO DG44-derived cell lines. The modifications conferred increases of 56-94% in S-phase fractions and decreases of 33-43% in early-stage apoptosis fractions. Clone 6.3, which expressed the highest levels of survivin and cyclin D1, reached significantly greater cell densities in suspension (2.7 × 10(6) cells/ml) following serum deprivation. Nude mice inoculated with the modified cells showed no tumorigenesis suggesting that the CHO DG44-derived cell lines are viable candidates for biopharmaceutical production."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.org/dc/terms/identifier"doi:10.1007/s10529-011-0577-9"xsd:string
http://purl.uniprot.org/citations/21380526http://purl.org/dc/terms/identifier"doi:10.1007/s10529-011-0577-9"xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Chen W."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Chen W."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Hou L."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Hou L."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Fu L."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Fu L."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Guo J."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Guo J."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Yu Y."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Yu Y."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Zhao X."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Zhao X."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Yi S."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Yi S."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Yu T."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/author"Yu T."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/date"2011"xsd:gYear
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/date"2011"xsd:gYear
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/name"Biotechnol. Lett."xsd:string
http://purl.uniprot.org/citations/21380526http://purl.uniprot.org/core/name"Biotechnol Lett"xsd:string